Company / Current Assets per Share
PTC Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$29.26
FY2025
5-year range
$9.80 / $29.26
FY2021-FY2025
Trend
+62.2%
vs FY2024
Sector context
#18 of 210
Health Care
What the data says
Among 210 Health Care companies, PTC Therapeutics, Inc. is in the top 9% for current assets per share. Current Assets per Share has increased for 3 consecutive years, from $9.80 in FY2022 to $29.26 in FY2025.
Based on SEC 10-K filings.
29.26 in FY2025 with a 5-year CAGR of +8.0%. Top quartile in the Health Care sector.
Improved from $16.67 to $29.26 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +44.0%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
-78.2% below sector average
Key checks
Key Insights
- PTC Therapeutics, Inc.'s current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 62.2% year-over-year.
- Ranks #18 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.26 | +62.2% |
| FY2024 | $18.04 | +8.2% |
| FY2023 | $16.67 | +70.2% |
| FY2022 | $9.80 | -28.4% |
| FY2021 | $13.69 | -31.2% |
| FY2020 | $19.89 | +50.2% |
| FY2019 | $13.24 | +71.7% |
| FY2018 | $7.71 | +5.8% |
| FY2017 | $7.29 | -5.4% |
| FY2016 | $7.70 | -28.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026